Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00299871
Status:
COMPLETED
Last Update Posted:
2014-01-28
First Post:
2006-03-06
Brief Title:
Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus
Sponsor:
Sanofi
Organization:
Sanofi
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Type 2 Diabetes |
Keywords:
| Name | View |
|---|---|
| Type 2 diabetes | View |